Articles

The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting its sales in the process.

Pricing power and lack of competition are driving Nvidia’s growth, but rivals are gaining traction.

The aerospace giant’s self-inflicted woes hold broader lessons on how to run a company.

Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.

Costco saw a 9.4% sales boost the five weeks through April 7, driven by a surge in e-commerce activity. .

Shares of Honest Co. fell Wednesday after it lost rights to use the name and likeness of founder Jessica Alba.

Rent the Runway Inc. on Wednesday said it expected breakeven free cash flow this year, following cost cuts and signs of a revival in shoppers’ enthusiasm.

Investors are abandoning bets that the Federal Reserve will cut interest rates three times in 2024, removing a critical safety net for stocks.

Inflation is remaining hotter than expected for longer than the Federal Reserve would like — and policy makers may have no one to blame but themselves, according to one economist.

Nvidia’s $2.2 trillion market cap, once seen as “unfathomable,” could head even higher, according to Morgan Stanley.

Cattle producers fret about market transparency after USDA cancels its July cattle report due to budget constraints.

Uniswap Labs has received a notice from the Securities and Exchange Commission that it will soon be charged with violating federal securities laws, its CEO Hayden Adams said in a post on X Wednesday.